Healthcare
Key Contacts
Managing Director /New York
Sean Cannon
Education
Mr. Cannon holds a BS in Finance from Lehigh University and holds FINRA Series 24, 50, 63, and 79 licenses.
Years of Experience
14+Career Highlights
Prior to joining GLC, Mr. Cannon worked at CRT Capital where he focused on investment banking advisory assignments across M&A and private capital raising.
Prior to joining CRT, Mr. Cannon worked in the Transaction Services practice at KPMG where he focused on M&A advisory services.
In 2023, Mr. Cannon received the 14th Annual Emerging Leaders Award by The M&A Advisor. The award recognizes professionals under 40 who have reached a significant level of success in their careers and made notable contributions to their industry and community.
Bio
Sean Cannon is a Managing Director at GLC with over 14 years of investment banking experience. Mr. Cannon joined GLC in 2013 and has advised companies, creditors and sponsors on over $33 billion of transactions including restructurings, recapitalizations, financings, mergers and acquisitions across a range of industry sectors including healthcare, consumer, retail, gaming, media, telecom and tax-exempt finance.
Examples of Mr. Cannon’s recent transactions include Carestream Health, Endo International, Great Lakes Senior Living, iHeartMedia, Healogics, Hertz, JCPenny, McClatchy, Stimwave Technologies, Toys R Us, and the Commonwealth of Puerto Rico, among others.
Managing Director /New York
Alex Geier
Education
Mr. Geier holds FINRA Series 24, 50, 63 and 79 licenses as well as an MBA from the Kellogg School at Northwestern University and an AB in Political Science and Economics from Duke University.
Years of Experience
25+Career Highlights
Mr. Geier was most recently with BMO Financial Group, where he ran the Healthcare Sponsor Finance team for 6 years, and also served as a Managing Director covering Healthcare in the Leveraged Finance Group of BMO Capital Markets. Prior to joining BMO, Mr. Geier spent 12 years at UBS in Healthcare-focused roles in Leveraged Finance, Capital Markets and High Yield Research. He previously covered the sector as a High Yield Analyst at BT Alex.Brown and Bank of America.
Overall, Mr. Geier has worked on more than 200 Healthcare assignments, encompassing a wide range of transaction types (restructurings, mergers and acquisitions, leveraged buyouts, carve-outs, dividend and other recapitalizations, exit financings, refinancings and growth capital) and financing instruments (1st and 2nd-lien loans, high yield bonds and bridge loans, unitranche facilities, mezzanine debt and preferred and common equity).
Bio
Alex Geier joined GLC in 2020 and leads the firm’s Healthcare practice. He has more than 25 years of overall experience across Services, Digital Health/HCIT, Medical Devices and Life Sciences, as well as deep subject matter expertise in the public and private credit markets. Representative transactions at GLC include Carestream Health, Healogics, Invacare, SpineOne and StimWave Technologies.
Managing Director /New York
J. Soren Reynertson
Education
Mr. Reynertson has successfully completed the following FINRA Administered Qualification Examinations: Series 7, 24, 50, 54 & 63. Mr. Reynertson passed the Financial Services Authority (FSA) Securities Exam in the UK including CF21 (Investment Adviser) and CF309 (Customer). Mr. Reynertson held a gaming license with the State of Pennsylvania.
Mr. Reynertson received a BA from Emory University and an MBA from Columbia Business School.
Years of Experience
25+Career Highlights
Before founding GLC Advisors, Mr. Reynertson was a Managing Director in UBS’ Restructuring & Leveraged Finance Group based in New York. Previously, Mr. Reynertson was a Managing Director and Head of the European Strategic Finance Group at Morgan Stanley in London. Prior to joining Morgan Stanley, Mr. Reynertson also held various roles within UBS’ Restructuring team in New York and London including Managing Director and Head of UBS’ European Restructuring team.
Mr. Reynertson was also a crisis manager for Jay Alix Associates (now AlixPartners) where he focused on taking operational roles in financially distressed businesses. Mr. Reynertson also worked in PriceWaterhouse’s (now PwC’s) Dispute Analysis and Corporate Recovery Group in New York, providing advisory services to troubled companies and their creditors.
Bio
Soren Reynertson is a Managing Director and the Managing General Partner of GLC Advisors, which he co-founded in 2009. Based in the New York office, he has worked with companies and their creditors on numerous assignments including bankruptcy reorganizations, exchange offers, out-of-court workouts, M&A, financings and recapitalizations. Recent assignments include roles in: Hertz, iHeart, First Energy Solutions, Riverbed Technologies, City of Detroit, Jefferson County, LBI ehf. (formerly Landsbanki Íslands hf.), Puerto Rico, Brookstone, Caesars, Foxwoods, Basic Energy, Radio Shack, Rivers Casino, Healogics, City of Atlantic City and Toys R Us.
Mr. Reynertson is a regular guest lecturer on several college campuses, including Columbia University, Emory University, UCLA, University of Chicago and the University of Pennsylvania.
Education
Mr. Reynertson has successfully completed the following FINRA Administered Qualification Examinations: Series 7, 24, 50, 54 & 63. Mr. Reynertson passed the Financial Services Authority (FSA) Securities Exam in the UK including CF21 (Investment Adviser) and CF309 (Customer). Mr. Reynertson held a gaming license with the State of Pennsylvania.
Mr. Reynertson received a BA from Emory University and an MBA from Columbia Business School.
Education
Mr. Cannon holds a BS in Finance from Lehigh University and holds FINRA Series 24, 50, 63, and 79 licenses.
Years of Experience
14+Career Highlights
Prior to joining GLC, Mr. Cannon worked at CRT Capital where he focused on investment banking advisory assignments across M&A and private capital raising.
Prior to joining CRT, Mr. Cannon worked in the Transaction Services practice at KPMG where he focused on M&A advisory services.
In 2023, Mr. Cannon received the 14th Annual Emerging Leaders Award by The M&A Advisor. The award recognizes professionals under 40 who have reached a significant level of success in their careers and made notable contributions to their industry and community.
Bio
Sean Cannon is a Managing Director at GLC with over 14 years of investment banking experience. Mr. Cannon joined GLC in 2013 and has advised companies, creditors and sponsors on over $33 billion of transactions including restructurings, recapitalizations, financings, mergers and acquisitions across a range of industry sectors including healthcare, consumer, retail, gaming, media, telecom and tax-exempt finance.
Examples of Mr. Cannon’s recent transactions include Carestream Health, Endo International, Great Lakes Senior Living, iHeartMedia, Healogics, Hertz, JCPenny, McClatchy, Stimwave Technologies, Toys R Us, and the Commonwealth of Puerto Rico, among others.
Education
Mr. Reynertson has successfully completed the following FINRA Administered Qualification Examinations: Series 7, 24, 50, 54 & 63. Mr. Reynertson passed the Financial Services Authority (FSA) Securities Exam in the UK including CF21 (Investment Adviser) and CF309 (Customer). Mr. Reynertson held a gaming license with the State of Pennsylvania.
Mr. Reynertson received a BA from Emory University and an MBA from Columbia Business School.
Education
Mr. Geier holds FINRA Series 24, 50, 63 and 79 licenses as well as an MBA from the Kellogg School at Northwestern University and an AB in Political Science and Economics from Duke University.
Years of Experience
25+Career Highlights
Mr. Geier was most recently with BMO Financial Group, where he ran the Healthcare Sponsor Finance team for 6 years, and also served as a Managing Director covering Healthcare in the Leveraged Finance Group of BMO Capital Markets. Prior to joining BMO, Mr. Geier spent 12 years at UBS in Healthcare-focused roles in Leveraged Finance, Capital Markets and High Yield Research. He previously covered the sector as a High Yield Analyst at BT Alex.Brown and Bank of America.
Overall, Mr. Geier has worked on more than 200 Healthcare assignments, encompassing a wide range of transaction types (restructurings, mergers and acquisitions, leveraged buyouts, carve-outs, dividend and other recapitalizations, exit financings, refinancings and growth capital) and financing instruments (1st and 2nd-lien loans, high yield bonds and bridge loans, unitranche facilities, mezzanine debt and preferred and common equity).
Bio
Alex Geier joined GLC in 2020 and leads the firm’s Healthcare practice. He has more than 25 years of overall experience across Services, Digital Health/HCIT, Medical Devices and Life Sciences, as well as deep subject matter expertise in the public and private credit markets. Representative transactions at GLC include Carestream Health, Healogics, Invacare, SpineOne and StimWave Technologies.
Education
Mr. Reynertson has successfully completed the following FINRA Administered Qualification Examinations: Series 7, 24, 50, 54 & 63. Mr. Reynertson passed the Financial Services Authority (FSA) Securities Exam in the UK including CF21 (Investment Adviser) and CF309 (Customer). Mr. Reynertson held a gaming license with the State of Pennsylvania.
Mr. Reynertson received a BA from Emory University and an MBA from Columbia Business School.
Education
Mr. Reynertson has successfully completed the following FINRA Administered Qualification Examinations: Series 7, 24, 50, 54 & 63. Mr. Reynertson passed the Financial Services Authority (FSA) Securities Exam in the UK including CF21 (Investment Adviser) and CF309 (Customer). Mr. Reynertson held a gaming license with the State of Pennsylvania.
Mr. Reynertson received a BA from Emory University and an MBA from Columbia Business School.
Years of Experience
25+Career Highlights
Before founding GLC Advisors, Mr. Reynertson was a Managing Director in UBS’ Restructuring & Leveraged Finance Group based in New York. Previously, Mr. Reynertson was a Managing Director and Head of the European Strategic Finance Group at Morgan Stanley in London. Prior to joining Morgan Stanley, Mr. Reynertson also held various roles within UBS’ Restructuring team in New York and London including Managing Director and Head of UBS’ European Restructuring team.
Mr. Reynertson was also a crisis manager for Jay Alix Associates (now AlixPartners) where he focused on taking operational roles in financially distressed businesses. Mr. Reynertson also worked in PriceWaterhouse’s (now PwC’s) Dispute Analysis and Corporate Recovery Group in New York, providing advisory services to troubled companies and their creditors.
Bio
Soren Reynertson is a Managing Director and the Managing General Partner of GLC Advisors, which he co-founded in 2009. Based in the New York office, he has worked with companies and their creditors on numerous assignments including bankruptcy reorganizations, exchange offers, out-of-court workouts, M&A, financings and recapitalizations. Recent assignments include roles in: Hertz, iHeart, First Energy Solutions, Riverbed Technologies, City of Detroit, Jefferson County, LBI ehf. (formerly Landsbanki Íslands hf.), Puerto Rico, Brookstone, Caesars, Foxwoods, Basic Energy, Radio Shack, Rivers Casino, Healogics, City of Atlantic City and Toys R Us.
Mr. Reynertson is a regular guest lecturer on several college campuses, including Columbia University, Emory University, UCLA, University of Chicago and the University of Pennsylvania.
Service Overview
GLC’s team brings a distinctive and dedicated approach to coverage of the Healthcare sector. Our professionals have advised on a range of complex transactions including M&A, debt financing and restructuring & recapitalizations, and our institutional knowledge spans the full spectrum of sub-sectors in this constantly evolving industry.
Our clients include corporations, creditors, entrepreneurs, and financial sponsors.
Healthcare
Industry Specialties
- Healthcare Facilities
- Physician Groups
- Home and Hospice Care
- Behavioral Care
- Dental and Orthodontic Care
- Digital Health
- Healthcare IT and Tech-enabled Services
- Labs and Diagnostics
- Managed Care and Payer Services
- Medical Devices and Equipment
- Biotechnology
- Pharmaceuticals
- Pharma Services
Recent Transactions
Our firm is built on providing a strong culture of collegial teamwork, designed to directly benefit our clients. Our professionals bring vast advisory experience from leading Wall Street firms. Our team has an unparalleled track record of providing exceptional results for our clients.
Learn More About Our Firm